Planet 13 Holdings (PLNH) Operating Income (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Operating Income of -$5.7 million for Q1 2026, up 14.16% year-over-year from -$5.0 million in Q1 2025, and down 23.31% quarter-over-quarter from -$4.6 million in Q4 2025.
Planet 13 Holdings (PLNH) Operating Income (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Operating Income for 6 consecutive years, with -$5.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income rose 14.16% year-over-year to -$5.7 million; the TTM figure through Mar 2026 stood at -$58.4 million (down 51.71% YoY), while the FY2025 annual figure was -$59.3 million, down 66.93% from the prior year.
- Operating Income eased to -$5.7 million in Q1 2026 per PLNH's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Operating Income topped out at -$1.8 million in Q2 2022 and bottomed at -$44.0 million in Q3 2023.
- Historically, Operating Income has averaged -$12.4 million across 5 years, with a median of -$4.6 million in 2025.
- Annual changes were most pronounced in 2022 — Operating Income slumped 1661.71% — and 2024, when it surged 92.44%.
- Planet 13 Holdings' Operating Income stood at -$38.8 million in 2022, then soared by 76.39% to -$9.2 million in 2023, then sank by 172.45% to -$25.0 million in 2024, then jumped by 81.57% to -$4.6 million in 2025, then declined by 23.31% to -$5.7 million in 2026.
- Business Quant data shows PLNH's Operating Income at -$5.7 million in Q1 2026, -$4.6 million in Q4 2025, and -$41.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Planet 13 Holdings | 46.72 Mn | 30.24 Mn | 12.32 Mn | -2.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.88 Mn |
| Mar 31, 2026 | -5.68 Mn |
| Dec 31, 2025 | -4.60 Mn |
| Sep 30, 2025 | -41.25 Mn |
| Jun 30, 2025 | -6.83 Mn |
| Mar 31, 2025 | -6.61 Mn |
| Dec 31, 2024 | -24.98 Mn |
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | -3.54 Mn |
| Mar 31, 2024 | -3.67 Mn |
| Dec 31, 2023 | -9.17 Mn |
| Sep 30, 2023 | -44.00 Mn |
| Jun 30, 2023 | -3.50 Mn |
| Mar 31, 2023 | -4.43 Mn |
| Dec 31, 2022 | -38.84 Mn |
| Sep 30, 2022 | -4.39 Mn |
| Jun 30, 2022 | -1.82 Mn |
| Mar 31, 2022 | -3.71 Mn |
| Dec 31, 2021 | 2.49 Mn |
| Sep 30, 2021 | -6.93 Mn |